Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: NASDAQ

October 23, 2026

Understanding Inducement Grants: A Look at Nektar Therapeutics’ Recent Disclosure

NASDAQ: $NKTR What Are Inducement Grants? In the world of corporate governance, transparency is key. Recently, Nektar Therapeutics (NASDAQ: NKTR) issued a formal report regarding the granting of equity awards to new employees. These types of transactions are often referred to as inducement grants. The Details Behind the Disclosure On August 29, 2019, Nektar Therapeutics…

Announcements

$NKTR, Corporate Governance, Equity Awards, Inducement Grants, NASDAQ, Nektar Therapeutics, pr-newswire
October 9, 2026

BioAffinity Technologies Secures $4 Million in New Strategic Financing

NASDAQ: $BIAF Strengthening the Path Forward BioAffinity Technologies, a company recognized for its innovative work in respiratory diagnostics, has officially announced the successful closing of a $4 million registered direct financing. This capital raise, facilitated by WallachBeth Capital, marks a significant milestone for the firm as it continues to advance its commercial and operational goals.…

Announcements

$BIAF, BioAffinity Technologies, Biotechnology, Financing, NASDAQ, pr-newswire, WallachBeth Capital

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Subscribe For A Premium Report To Maximize Your Returns

The FREE bio tech stock catalyst report ONLY includes companies with catalysts within the current week. Often, this may not be enough time to capture the pre-catalyst stock price movements. For MAX RETURNS. Subscribe to a premium report type below and you will receive reports with a longer outlook, allowing you to discover earlier entries to be positioned before a price move happens. Don’t miss out, maximize your return potential!

Choose your outlook window (each priced accordingly)

Get FREE Biotech Stock Catalyst Reports

Email